Lactobacillus casei extract induces apoptosis in gastric cancer by inhibiting NF-κB and mTOR-mediated signaling

Integrative Cancer Therapies

Volumn 12, Issue 2, 2013, Pages 165-173

  Hwang, Jeong Won ^a   Baek, Young Mi ^b   Yang, Kyeong Eun ^a   Yoo, Hwa Seung ^b   Cho, Chong Kwan ^b   Lee, Yeon Weol ^b   Park, Junsoo ^c   Eom, Chi Yong ^a   Lee, Zee Won ^a   Choi, Jong Soon ^a,d   Jang, Ik Soon ^a  

^a Korea Basic Science Institute (KBSI)   (South Korea)

^b Daejeon University   (South Korea)

^c Yonsei University Wonju   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

Apoptosis; Gastric cancer; KATO3; Lactobacillus casei; MTOR; NF B

Indexed keywords

CASPASE 3; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTOBACILLUS CASEI EXTRACT; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; S6 KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; IMMUNOBLOTTING; IN VITRO STUDY; LACTOBACILLUS CASEI; PHASE CONTRAST MICROSCOPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; WESTERN BLOTTING;

APOPTOSIS; BIOLOGICAL AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; I-KAPPA B PROTEINS; LACTOBACILLUS CASEI; MAP KINASE SIGNALING SYSTEM; MITOCHONDRIA; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; TOR SERINE-THREONINE KINASES;

EID: 84874270359     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735412442380     Document Type: Article

References (38)

1. Forestier C, Champs CD, Vatoux C, Joly B. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res Microbiol. 2001;152: 167-173.
2. Hudault S, Lievin V, Bernet-Camard MF, Servin AL. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl Environ Microbiol. 1997;63: 513-518.
3. Molin G, Jeppsson B, Johansson ML, et al. Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. J Appl Bacteriol. 1993;74: 314-323.
4. Kim TI, Lee YC, Lee KH, et al. Effects of nonsteroidal antiinflammatory drugs on Helicobacter pylori-infected gastric mucosae of mice: apoptosis, cell proliferation, and inflammatory activity. Infect Immun. 2001;69: 5056-5063.
5. Sovak M, Seligson AL, Konas M, et al. Herbal composition PC-SPES for management of prostate cancer: identification of active principles. J Natl Cancer Inst. 2002;94: 1275-1281.
6. Subbaramaiah K, Cole PA, Dannenberg AJ. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREBbinding protein/p300-dependent and -independent mechanisms. Cancer Res. 2002;62: 2522-2530.
7. Kelsen DP. Adjuvant and neoadjuvant therapy for gastric cancer. Semin Oncol. 1996;23: 379-389.
8. Sawaoka H, Kawano S, Tsuji S, et al. Cyclooxygenase-2 inhibitors suppress the growth of gastric cancer xenografts via induction of apoptosis in nude mice. Am J Physiol. 1998;274:G1061-G1067.
9. Lang SA, Gaumann A, Koehl GE, et al. Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental model. Int J Cancer. 2007;120: 1803-1810.
10. Yeo EJ, Hwang YC, Kang CM, et al. Senescence-like changes induced by hydroxyurea in human diploid fibroblasts. Exp Gerontol. 2000;35: 553-571.
11. Orton RJ, Sturm OE, Vyshemirsky V, Calder M, Gilbert DR, Kolch W. Computational modelling of the receptor-tyrosinekinase- activated MAPK pathway. Biochem J. 2005; 392: 249-261.
12. Vousden KH. p53: death star. Cell. 2000;103: 691-694.
13. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science. 2005;307: 1098-1101.
14. Lilly DM, Stillwell RH. Probiotics: growth-promoting factors produced by microorganisms. Science. 1965;147: 747-748.
15. Kirjavainen PV, El-Nezami HS, Salminen SJ, Ahokas JT, Wright PF. The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. FEMS Immunol Med Microbiol. 1999;26: 131-135.
16. Gill HS, Rutherfurd KJ, Prasad J, Gopal PK. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr. 2000;83: 167-176.
17. Pessi T, Sutas Y, Hurme M, Isolauri E. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clinical and experimental allergy. J Br Soc Allergy Clin Immunol. 2000;30: 1804-1808.
18. Haller D, Blum S, Bode C, Hammes WP, Schiffrin EJ. Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun. 2000;68: 752-759.
19. Hessle C, Andersson B, Wold AE. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram-negative bacteria preferentially stimulate IL-10 production. Infect Immun. 2000;68: 3581-3586.
20. Hessle C, Hanson LA, Wold AE. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol. 1999;116: 276-282.
21. Miettinen M, Matikainen S, Vuopio-Varkila J, et al. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun. 1998;66: 6058-6062.
22. Matsuguchi T, Takagi A, Matsuzaki T, et al. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin Diagn Lab Immunol. 2003;10: 259-266.
23. Miettinen M, Lehtonen A, Julkunen I, Matikainen S. Lactobacilli and Streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J Immunol. 2000;164: 3733-3740.
24. Kim YG, Ohta T, Takahashi T, et al. Probiotic Lactobacillus casei activates innate immunity via NF-kappaB and p38 MAP kinase signaling pathways. Microbes Infect. 2006;8: 994-1005.
25. Kato I, Endo-Tanaka K, Yokokura T. Suppressive effects of the oral administration of Lactobacillus casei on type II collageninduced arthritis in DBA/1 mice. Life Sci. 1998;63: 635-644.
26. Biffi A, Coradini D, Larsen R, Riva L, Fronzo GD. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr Cancer. 1997;28: 93-99.
27. Fichera GA, Giese G. Non-immunologically-mediated cytotoxicity of Lactobacillus casei and its derivative peptidoglycan against tumor cell lines. Cancer Lett. 1994;85: 93-103.
28. Mow BM, Blajeski AL, Chandra J, Kaufmann SH. Apoptosis and the response to anticancer therapy. Curr Opin Oncol. 2001;13: 453-462.
29. Mohamad N, Gutierrez A, Nunez M, et al. Mitochondrial apoptotic pathways. Biocell. 2005;29: 149-161.
30. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 1997;275: 1132-1136.
31. Thees S, Hubbard GB, Winckler J, Schultz C, Rami A. Specific alteration of the Bax/Bcl2 ratio and cytochrome c without execution of apoptosis in the hippocampus of aged baboons. Restor Neurol Neurosci. 2005;23: 1-9.
32. Chung VQ, Tattersall M, Cheung HT. Interactions of a herbal combination that inhibits growth of prostate cancer cells. Cancer Chemother Pharmacol. 2004;53: 384-390.
33. Suzuki A, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K. Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A. Cell Death Differ. 2000;7: 721-728.
34. Aggarwal BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol. 2003;3: 745-756.
35. Fingar DC, Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene. 2004;23: 3151-3171.
36. Richardson CJ, Schalm SS, Blenis J. PI3-kinase and TOR: PIKTORing cell growth. Semin Cell Dev Biol. 2004;15: 147-159.
37. Tokunaga C, Yoshino K, Yonezawa K. mTOR integrates amino acid- and energy-sensing pathways. Biochem Biophys Res Commun. 2004;313: 443-446.
38. Shaw RJ, Cantley LC. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature. 2006;441:424-430.